Laboratory Products and Services Outsourcing Market Size & Forecast
The global laboratory products and services outsourcing market was valued at USD 41.85 billion in 2024 and is expected to reach USD 78.67 billion by 2032, expanding at a compound annual growth rate (CAGR) of 8.22% during the forecast period of 2025 to 2032, according to a research study conducted by SNS Insider.
This market encompasses a broad spectrum of outsourced services and products, ranging from high-precision equipment, disposables, and analytical tools to bioanalytical, pharmaceutical, and medical device-related laboratory services. Organizations across the pharmaceutical, biotechnology, and medical device sectors are increasingly partnering with Contract Research Organizations (CROs) and Contract Development and Manufacturing Organizations (CDMOs) to enhance productivity, reduce operational burden, and access specialized capabilities.
Get a Free Sample Report of Laboratory Products and Services Outsourcing Market @ https://www.snsinsider.com/sample-request/7672
Growth Drivers
A significant driver of the laboratory products and services outsourcing market is the mounting demand for cost containment and efficiency in pharmaceutical and biotechnology companies. The rising costs associated with in-house laboratory operations—spanning equipment maintenance, skilled workforce, and regulatory compliance—have compelled organizations to seek third-party outsourcing to remain competitive. Furthermore, as the complexity of drug development increases, particularly in personalized medicine, there is a higher reliance on niche expertise in areas like bioequivalence studies, pharmacokinetics (PK), pharmacodynamics (PD), and analytical method development.
Technological advancements also play a critical role in driving market growth. Integration of next-generation diagnostics technologies such as mass spectroscopy, immunoassays, flow cytometry, and molecular diagnostics has enhanced accuracy, throughput, and turnaround times, thereby attracting pharmaceutical and medical device companies to external labs offering these services. Moreover, stringent regulatory requirements for biocompatibility testing, stability testing, and sterility validation across developed markets have further accelerated the outsourcing trend, particularly in the medical device sector.
The surge in biologics and biosimilars development is another key growth catalyst. Biotech firms prefer outsourcing their laboratory needs for bioanalytical testing, extractable and leachable studies, and method validation due to the capital-intensive nature of biologics R&D. Additionally, emerging markets in Asia Pacific and Latin America are witnessing increased activity from global CROs and CDMOs due to favorable government regulations, low-cost infrastructure, and a growing pool of skilled professionals.
Market Segmentation Overview
The laboratory outsourcing market is segmented by Type into Products and Services. Product categories include general, analytical, clinical, specialty equipment, disposables, and support tools, while services range from pharmaceutical method development to stability testing and technical consulting. The Services segment dominates the market due to high demand for bioanalytical and drug development-related testing.
By Technology, the market is driven by a diverse set of diagnostic tools, including immunoassays, molecular diagnostics, clinical chemistry, microbiology, chromatography, and flow cytometry. The increasing complexity of drug formulations and precision diagnostics has made these technologies indispensable in outsourcing laboratories.
In terms of End Use, pharmaceutical and biotech companies represent the largest segment, followed by medical device companies and CROs/CDMOs. These organizations outsource laboratory services to streamline workflows, reduce time-to-market, and meet regulatory compliance efficiently.
Regional Outlook
North America holds a dominant share of the global market, attributed to the strong presence of pharmaceutical giants, established CROs/CDMOs, and robust regulatory frameworks. However, Asia Pacific is expected to grow at the fastest pace over the forecast period, supported by favorable outsourcing trends, rising R&D investments, and increasing adoption of laboratory automation technologies.
Key Market Players
Major players contributing to the global laboratory products and services outsourcing market include Thermo Fisher Scientific, Eurofins Scientific, Charles River Laboratories, LabCorp, SGS SA, IQVIA, WuXi AppTec, Medpace Holdings, ICON plc, and PPD (a part of Thermo Fisher). These companies are expanding service portfolios through acquisitions and partnerships to cater to evolving client requirements and ensure regulatory readiness.
Buy a Single-User PDF of Laboratory Products and Services Outsourcing Market Analysis & Outlook Report @ https://www.snsinsider.com/checkout/7672
Recent Developments
In February 2024, Thermo Fisher Scientific announced the expansion of its analytical services division with a new facility in Massachusetts aimed at serving biotech clients with advanced method validation and stability testing.
In June 2023, Charles River Laboratories partnered with a major Asian CDMO to enhance bioanalytical capabilities in the APAC region, focusing on small molecule and biologics testing.
As outsourcing continues to evolve from a cost-saving measure to a strategic function in R&D and quality assurance, the laboratory products and services outsourcing market is poised for sustained growth. Companies leveraging this model stand to benefit from access to specialized skills, cutting-edge technologies, and enhanced compliance—all while accelerating innovation and improving ROI.
Read Our Other Report
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
Contact Us:
Jagney Dave – Vice President of Client Engagement
Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)
Email: [email protected]
